Africa: 2019 DELTAS Africa Scientific Conference. - Interview of Aminatou Kone, a post-Doc fellow of MARCAD
[allAfrica] This conference "was also a platform for this young generation to express their views about how they perceive the future of science in Africa. We will leave here with new motivations and more opportunities."
ConclusionAlthough malaria remains a serious disease affecting millions of people, medicinal plants while used extensively, have not been given the attention warranted for further investigation.Graphical abstract
CONCLUSION: For appropriate vaccination, pre-travel consultation at least 3 weeks before departure is crucial. Travelers should be aware of required vaccination and malaria prophylaxis before visiting South and Central America and Asia. Plans to enhance compliance of the elderly and business travelers should be contrived. PMID: 31436051 [PubMed - in process]
[Premium Times] Strategic plans to reduce the double burden of malnutrition and malaria in the African region are being fashioned out at the 69th Regional Committee meeting of the World Health Organisation (WHO) holding in the Congo Republic.
The body said the current vaccine and control methods would not likely work.
LONDON, Aug 23 - Eradicating malaria is biologically feasible and a lofty aim, the World Health Organization said on Friday, but the focus for now should be getting the funds, tools and political will to control it.
The World Health Organization says it's theoretically possible to wipe out malaria, but probably not with the flawed vaccine and other control methods being used at the moment
Three-year review says new vaccines for eradicating disease are only 40% effectiveMalaria will not be eradicated in the foreseeable future even though it is achievable and would save millions of lives, according to World Health Organization (WHO) experts following a three-year review.The WHO remains committed to the “disappearance of every single malaria parasite from the face of the planet”, as it has been since the UN organisation was launched in 1948, said Dr Pedro Alonso, the director of its global malaria programme.Continue reading...
The chloroquine resistance transporter PfCRT of the human malaria parasite Plasmodium falciparum confers resistance to the former first-line antimalarial drug chloroquine, and it modulates the responsiveness to a wide range of quinoline and quinoline-like compounds. PfCRT is post-translationally modified by phosphorylation, palmitoylation, and, possibly, ubiquitination. However, the impact of these post-translational modifications on P. falciparum biology and, in particular, the drug resistance–conferring activity of PfCRT has remained elusive. Here, we confirm phosphorylation at Ser-33 and Ser-411 of PfCRT of the ch...
ConclusionsOnchocerciasis-endemic sites would doubly benefit from ivermectin MDA interventions, as these will alleviate onchocerciasis-associated morbidity and mortality, while potentially curbing malaria transmission. Involving onchocerciasis programs and other relevant stakeholders in the malaria/ivermectin research agenda would foster the implementation of pluri-annual MDA in target communities.